Advaxis, Inc. - “Georgia Regents Trials”

Publishing & Media

Share Tweet

Advaxis, Inc. - “Georgia Regents Trials”

Advaxis Inc. (NASDAQ:ADXS) today published a new blog post on The Chairman's Blog, written by the company's COO, Mr. Gregory T. Mayes. is an exclusive online media publication that provides key executive officers and key opinion leaders a unique platform to share insights about company and industry trends.

Mr. Mayes blogs about the company's recently announced collaboration with GRU Cancer Center at Georgia Regents University. In it, he speaks about how Advaxis plans on expanding its existing relationship with GRU Cancer Center and Dr. Khleif to harness "the power and strength of the caner immunotherapy research at GRU."  Read the full blog post on (

About Advaxis, Inc.

Advaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete an antigen/adjuvant fusion protein(s) that is designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself.

ADXS-HPV is currently being evaluated in Phase 1 and 2 clinical trials for HPV-associated cancers: recurrent cervical cancer (completed Phase 2 study conducted in India), locally advanced cervical cancer (GOG/NCI U.S. study, Clinical Identifier NCT01266460), head & neck cancer (CRUK study, Clinical Identifier NCT01598792, Mt. Sinai study, Clinical Identifier NCT02002182), and anal cancer (BrUOG U.S. study, Clinical Identifier NCT01671488). Advaxis has over 15 distinct immunotherapies in various stages of development, developed directly by Advaxis and through strategic collaborations with recognized centers of excellence such as: the University of Pennsylvania, the Georgia Regents University Cancer Center, Icahn School of Medicine at Mount Sinai, and others.

For more information please visit:

About is an exclusive, online media publication where publically and privatively held firms alike share insights about their companies and industries. enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. In addition to management`s insightful blog posts, staff and aggregate partners contribute articles on finance, technology, health, and energy while providing updated market trends, news, and information.